Wang Qinghui: Male, Han nationality, born in 1980, party member, graduated from Dalian University of Technology with a Ph.D. in applied chemistry, and was a visiting scholar at George University in the United States to jointly train doctoral students; He used to be a senior researcher of Tianjin Wuxi PharmaTech New Drug Development Co., Ltd., a senior researcher, project leader and deputy director of the Institute of Chemical Medicine of Yang Zijiang Pharmaceutical Group, and a general manager, enterprise leader and quality licensor of Jiangsu Haici Biopharmaceutical Co., Ltd. of Yang Zijiang Pharmaceutical Group; He is currently the R&D registration director of the Medical Research Institute of Yang Zijiang Pharmaceutical Group. I am specialized in research and development, production, quality, engineering and operation management of chemical drugs. At present, he is also the vice chairman of Jiangsu International Service Outsourcing Association, the vice chairman of Jiangsu Biomedical Service Outsourcing Alliance and the member of the third committee of Taizhou Youth Federation. 20 1 1, Jiangsu province's "enterprise innovation doctor gathering plan" and Taizhou's "31/project" in the fifth phase, high-level talents won the second prize of the National Federation of Industry and Commerce, the third prize of Jiangsu Science and Technology Award and the second prize of Taizhou Science and Technology Progress Award. Undertaking major national SCIence and technology projects 1 and Taizhou scientific and technological achievements transformation project 1, publishing 5 papers of sci core journals and applying for patents 14. Led the team to carry out research and development and production registration of dozens of chemicals, new GMP certification of more than 20 varieties, 5 new production approvals and 3 supplementary approvals to improve drug quality standards, resulting in economic benefits of more than 2 billion yuan.